The role of solithromycin in the management of bacterial community-acquired pneumonia
- 5 February 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 14 (3) , 311-324
Abstract
The fluoroketolide solithromycin is 2-fold more potent in vitro than telithromycin against pneumococci (including macrolide-resistant strains) and Haemophilus influenzae and very active on pathogen...Keywords
Funding Information
- Belgian Fonds de la Recherche Scientifique
This publication has 66 references indexed in Scilit:
- Community-acquired pneumoniaThe Lancet, 2015
- Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- Community-acquired pneumonia in children: Current challenges and future directionsJournal of Infection, 2014
- Pneumococcal infection in adults: burden of diseaseClinical Microbiology and Infection, 2014
- The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- The Changing Microbiologic Epidemiology of Community-Acquired PneumoniaPostgraduate Medicine, 2013
- Long-term prognosis in community-acquired pneumoniaCurrent Opinion in Infectious Diseases, 2013
- The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Clinical and economic burden of community-acquired pneumonia among adults in EuropeThorax, 2010
- The Burden of Community‐Acquired Pneumonia in Seniors: Results of a Population‐Based StudyClinical Infectious Diseases, 2004